John B. Landis is a director of EyePoint Pharmaceuticals Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
EyePoint Pharmaceuticals, Inc.
9 Jan 24
4
EyePoint Pharmaceuticals, Inc.
22 Jun 23
4
EyePoint Pharmaceuticals, Inc.
13 Feb 23
4
EyePoint Pharmaceuticals, Inc.
11 Feb 22
4
EyePoint Pharmaceuticals, Inc.
23 Jun 21
4
EyePoint Pharmaceuticals, Inc.
2 Mar 21
4
EyePoint Pharmaceuticals, Inc.
3 Mar 20
4
EyePoint Pharmaceuticals, Inc.
27 Jun 19
4
EyePoint Pharmaceuticals, Inc.
15 May 19
4
EyePoint Pharmaceuticals, Inc.
29 Oct 18
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Jan 24 | EYPT EyePoint Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 20.4 | 25,014 | 510.29 k | 25,014 |
5 Jan 24 | EYPT EyePoint Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 20.4 | 20,000 | 408.00 k | 20,000 |
5 Jan 24 | EYPT EyePoint Pharmaceuticals | RSU Common Stock | Grant | Acquire A | No | No | 0 | 10,000 | 0.00 | 10,000 |
20 Jun 23 | EYPT EyePoint Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 3.5 | 13,000 | 45.50 k | 13,000 |
20 Jun 23 | EYPT EyePoint Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 3.26 | 26,100 | 85.09 k | 26,100 |
9 Feb 23 | EYPT EyePoint Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 0 | 3,000 | 0.00 | 11,400 |
9 Feb 23 | EYPT EyePoint Pharmaceuticals | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 3,000 | 0.00 | 0 |